Joined Today: 2

ACHN Achillion Pharmaceuticals,, Stock Message Board

All Messages

ACHN Message Board Home | Join The ACHN Group |

#7: ACHN Stock News : Achillion Granted U.S. Patent for NS4A Antagonists in Hepatitis C
TheMachine	May 25, 2009 05:49:10 PM
Receives Novel Mechanism of Action Claims as Inhibitor of Viral Replication NEW HAVEN, Conn., April 16, 2009 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc.... view message ignore post recommend post

#6: ACHN Stock News : Achillion Announces Appointment of New Head of Business Development
TheMachine	February 8, 2009 12:52:35 AM
NEW HAVEN, Conn., Jan. 7, 2009 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the... view message ignore post recommend post

#5: Achillion Appoints Nicholas Simon to Board of Directors
TheMachine	September 20, 2008 01:03:11 AM
NEW HAVEN, Conn., Aug. 20, 2008 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat... view message ignore post recommend post

#4: Achillion and FOB Synthesis Announce Collaboration for the Development of Carbapenem Compounds
Stock News Bot	April 13, 2008 03:49:15 PM
Achillion and FOB Synthesis Announce Collaboration for the Development of Carbapenem Compounds NEW HAVEN, Conn. and KENNESAW, Ga., April 8, 2008... view message ignore post recommend post

#3: New Data for Achillion's Elvucitabine Demonstrate Drug's Safety, Efficacy and Suitability for Combination Therapy in HIV-Infected Patients
TheMachine	February 10, 2008 06:21:23 AM
NEW HAVEN, Conn., Jan. 31, 2008 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development... view message ignore post recommend post

#2: Achillion Reports Safety and Potent Antiviral Activity in Topline Results From Elvucitabine Phase 2 Study in HIV-Infected Patients
FastFun	October 15, 2007 11:50:48 PM
NEW HAVEN, Conn., Oct. 15, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most... view message ignore post recommend post

#1: ACHN, Achillion Announces the Resignation of John C. Pottage, Jr., M.D., Senior Vice President and Chief Medical Officer
Jason	June 4, 2007 08:23:18 AM
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN Stock Forum) today announced that John C. Pottage, Jr., M.D., Senior Vice President and Chief Medical Officer, has resigned to accept a senior clinical... view message ignore post recommend post

Group Home | Login if you want to post a message